DENVER, July 10, 2025 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced plans to hold its second quarter 2025 results conference call...
MONTREAL and SAN FRANCISCO, July 10, 2025 /CNW/ - Coveo (TSX: CVO), the leader in AI-Relevance, delivering best-in-class search and generative experiences that maximize business...
MONTREAL and SAN FRANCISCO, July 10, 2025 /PRNewswire/ - Coveo (TSX: CVO), the leader in AI-Relevance, delivering best-in-class search and generative experiences that maximize business...
TORONTO, July 10, 2025 /CNW/ - Geodrill Limited ("Geodrill" or the "Company") (TSX: GEO) (OTCQX: GEODF), a leading West African based drilling company, announces that...
AUSTIN, Texas, July 9, 2025 /PRNewswire/ -- Flex (NASDAQ: FLEX) will announce its first quarter fiscal 2026 financial results before the market opens on...
COLUMBUS, Ohio, July 9, 2025 /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN) will release second quarter 2025 financial results prior to the market opening on Friday,...
CALGARY, AB, July 9, 2025 /PRNewswire/ - Vermilion Energy Inc. ("Vermilion", "We", "Our", or the "Company") (TSX: VET) (NYSE: VET) is pleased to announce...
VANCOUVER, BC, July 9, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) will hold a conference call on Monday, August 11th, 2025 at...
BETHESDA, Md., July 8, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) will broadcast its quarterly conference call with shareholders and the financial...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.
DALLAS, July 8, 2025 /PRNewswire/ -- Kimberly-Clark (NASDAQ: KMB) will issue its second quarter 2025 results on Friday, August 1. A press release and...
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital, annonce aujourd’hui le bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial.